4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-111702
President and CEO sold 500 shares at $24.00 ($12,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd President and CEO | 2024-09-30 | Sale 10b5-1 | −500 | $24.00 | $12,000 | 1,477,373 | D |
| Open-market sales · 500 sh · avg $24.00 · $12,000 | |||||||
Loading xslF345X05/ownership.xml…